Cambridge Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.95M | Sell |
5,069
-101
| -2% | -$56.7K | 0.11% | 105 |
|
|
2023
Q4 | $2.74M | Sell |
5,170
-574
| -10% | -$278K | 0.11% | 102 |
|
|
2023
Q3 | $2.91M | Sell |
5,744
-27
| -0.5% | -$14.4K | 0.13% | 97 |
|
|
2023
Q2 | $3.01M | Sell |
5,771
-551
| -9% | -$297K | 0.14% | 96 |
|
|
2023
Q1 | $3.64M | Sell |
6,322
-38
| -0.6% | -$21.4K | 0.17% | 91 |
|
|
2022
Q4 | $3.5M | Buy |
6,360
+86
| +1% | +$45.6K | 0.16% | 93 |
|
|
2022
Q3 | $3.18M | Buy |
6,274
+418
| +7% | +$234K | 0.15% | 98 |
|
|
2022
Q2 | $3.18M | Sell |
5,856
-22
| -0.4% | -$12.1K | 0.14% | 105 |
|
|
2022
Q1 | $3.47M | Buy |
5,878
+243
| +4% | +$140K | 0.12% | 107 |
|
|
2021
Q4 | $3.76M | Buy |
5,635
+1,867
| +50% | +$1.17M | 0.12% | 106 |
|
|
2021
Q3 | $2.15M | Buy |
3,768
+413
| +12% | +$227K | 0.08% | 105 |
|
|
2021
Q2 | $1.69M | Sell |
3,355
-89
| -3% | -$42K | 0.06% | 119 |
|
|
2021
Q1 | $1.57M | Sell |
3,444
-215
| -6% | -$103K | 0.06% | 117 |
|
|
2020
Q4 | $1.7M | Buy |
3,659
+443
| +14% | +$208K | 0.08% | 97 |
|
|
2020
Q3 | $1.42M | Sell |
3,216
-18
| -0.6% | -$7.44K | 0.07% | 101 |
|
|
2020
Q2 | $1.34M | Sell |
3,234
-375
| -10% | -$126K | 0.07% | 104 |
|
|
2020
Q1 | $1.02M | Sell |
3,609
-583
| -14% | -$184K | 0.07% | 112 |
|
|
2019
Q4 | $1.36M | Buy |
4,192
+211
| +5% | +$64K | 0.07% | 121 |
|
|
2019
Q3 | $1.16M | Sell |
3,981
-45
| -1% | -$12.9K | 0.07% | 122 |
|
|
2019
Q2 | $1.18M | Sell |
4,026
-455
| -10% | -$125K | 0.07% | 120 |
|
|
2019
Q1 | $1.23M | Sell |
4,481
-50
| -1% | -$12.4K | 0.07% | 123 |
|
|
2018
Q4 | $1.01M | Sell |
4,531
-75
| -2% | -$17.6K | 0.07% | 128 |
|
|
2018
Q3 | $1.12M | Buy |
4,606
+107
| +2% | +$24.6K | 0.06% | 129 |
|
|
2018
Q2 | $932K | Sell |
4,499
-141
| -3% | -$29.9K | 0.06% | 135 |
|
|
2018
Q1 | $958K | Sell |
4,640
-196
| -4% | -$41.1K | 0.06% | 136 |
|
|
2017
Q4 | $918K | Sell |
4,836
-92
| -2% | -$17.6K | 0.06% | 137 |
|
|
2017
Q3 | $932K | Buy |
4,928
+480
| +11% | +$86.9K | 0.06% | 132 |
|
|
2017
Q2 | $776K | Sell |
4,448
-1,675
| -27% | -$281K | 0.05% | 137 |
|
|
2017
Q1 | $941K | Sell |
6,123
-578
| -9% | -$88.3K | 0.06% | 139 |
|
|
2016
Q4 | $946K | Buy |
6,701
+378
| +6% | +$55.7K | 0.07% | 133 |
|
|
2016
Q3 | $1.01M | Buy |
6,323
+117
| +2% | +$18K | 0.07% | 126 |
|
|
2016
Q2 | $917K | Sell |
6,206
-2,110
| -25% | -$311K | 0.07% | 129 |
|
|
2016
Q1 | $1.18M | Buy |
8,316
+4,185
| +101% | +$561K | 0.1% | 110 |
|
|
2015
Q4 | $586K | Sell |
4,131
-400
| -9% | -$53.4K | 0.05% | 130 |
|
|
2015
Q3 | $554K | Buy |
4,531
+620
| +16% | +$80.8K | 0.05% | 135 |
|
|
2015
Q2 | $507K | Sell |
3,911
-170
| -4% | -$22.2K | 0.04% | 140 |
|
|
2015
Q1 | $548K | Buy |
4,081
+77
| +2% | +$9.93K | 0.05% | 139 |
|
|
2014
Q4 | $501K | Buy |
4,004
+139
| +4% | +$16.9K | 0.04% | 138 |
|
|
2014
Q3 | $471K | Buy |
3,865
+275
| +8% | +$33.4K | 0.04% | 136 |
|
|
2014
Q2 | $423K | Sell |
3,590
-925
| -20% | -$109K | 0.04% | 145 |
|
|
2014
Q1 | $543K | Sell |
4,515
-145
| -3% | -$17.2K | 0.05% | 128 |
|
|
2013
Q4 | $519K | Buy |
4,660
+400
| +9% | +$39.8K | 0.05% | 130 |
|
|
2013
Q3 | $392K | Sell |
4,260
-566
| -12% | -$51.2K | 0.04% | 137 |
|
|
2013
Q2 | $409K | Buy |
+4,826
| New | +$402K | 0.04% | 128 |
|
Other funds holding TMO
Cambridge Trust's TMO Position: Q1 2024 in Review
Cambridge Trust reduced its Thermo Fisher Scientific (TMO) stake by 2% in Q1 2024, selling an estimated $56.7K and leaving 5,069 shares worth $2.95M. The position accounts for 0.11% of the portfolio, ranked #105.
Cambridge Trust first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.76M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.
- Cambridge Trust held 5,069 shares of Thermo Fisher Scientific worth $2.95M as of Q1 2024.
- Cambridge Trust sold 101 Thermo Fisher Scientific shares in Q1 2024, an estimated $56.7K.
- Thermo Fisher Scientific made up 0.11% of Cambridge Trust's portfolio in Q1 2024, its #105 holding.
- Cambridge Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
- Cambridge Trust's Thermo Fisher Scientific position peaked at $3.76M in Q4 2021.
- 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.